‘Anti-Competitive’ Pharmaceuticals Group Facing Litigation Avalanche
A pharmaceuticals group which was fined more than Euros 330 million by the European Commission for anti-competitive conduct in relation to a drug used for treating heart disease is now also facing a tidal wave